|
ZENITH docs on SEDAR
|
2
|
Zenith Epigenetics
|
Nov 15, 2016 04:05PM
|
|
Re: ESPR got crushed today
|
2
|
Resverlogix Corp.
|
May 03, 2018 02:46PM
|
|
Re: Caroline Hill, Ph.D. Appointed SVP, Head of R&D Operations at Bioasis
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 26, 2018 04:51PM
|
|
Re: Tundup's message
|
2
|
Resverlogix Corp.
|
Apr 14, 2019 06:07PM
|
|
Re: More Than Just DSMB Green Light
|
2
|
Resverlogix Corp.
|
Nov 01, 2017 04:11PM
|
|
Re: Waiting for the shoe to drop....
|
2
|
Resverlogix Corp.
|
Apr 19, 2018 09:52AM
|
|
Re: Is Bioasis attending this BBB conference?
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 19, 2017 05:45PM
|
|
Re: How long would the last enrolled patient have to be in the trail before their stats would be included.
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 11:15PM
|
|
Re: I added a few!
|
2
|
Resverlogix Corp.
|
Jun 22, 2019 08:57AM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 21, 2018 11:36AM
|
|
Re: The Prescription
|
2
|
Resverlogix Corp.
|
Nov 16, 2017 10:18AM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 11:33AM
|
|
Re: balancing success and failure
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 07:25PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 24, 2020 12:56PM
|
|
Re: Pretty quiet on the Zenith front,
|
2
|
Zenith Epigenetics
|
Aug 03, 2018 03:56PM
|
|
Re: ESC 2016 Symposium
|
2
|
Resverlogix Corp.
|
Jun 15, 2016 01:53PM
|
|
Re: Zenith share issue
|
2
|
Zenith Epigenetics
|
Nov 14, 2017 12:34PM
|
|
Re: ...Crunch time..
|
2
|
Resverlogix Corp.
|
Sep 22, 2015 12:39PM
|
|
Re: Breakthrough Therapy Designation Application
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 09:42AM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 11:45AM
|
